Global CAR T-Cell Immunotherapy Market Status and Outlook 2021-2026

Table of Contents

Global CAR T-Cell Immunotherapy Market Status and Outlook 2021-2026

Market Study Overview
1.1 Study Objectives
1.2 CAR T-Cell Immunotherapy Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 CAR T-Cell Immunotherapy Segment by Type
2.1.1 Monotherapy
2.1.2 Combination Therapy
2.2 Market Analysis by Application
2.2.1 Hematologic Malignancies
2.2.2 Solid Malignancies
2.3 Global CAR T-Cell Immunotherapy Market Comparison by Regions (2016-2026)
2.3.1 Global CAR T-Cell Immunotherapy Market Size (2016-2026)
2.3.2 North America CAR T-Cell Immunotherapy Status and Prospect (2016-2026)
2.3.3 Europe CAR T-Cell Immunotherapy Status and Prospect (2016-2026)
2.3.4 Asia-pacific CAR T-Cell Immunotherapy Status and Prospect (2016-2026)
2.3.5 South America CAR T-Cell Immunotherapy Status and Prospect (2016-2026)
2.3.6 Middle East & Africa CAR T-Cell Immunotherapy Status and Prospect (2016-2026)
2.5 Coronavirus Disease 2019 (Covid-19): CAR T-Cell Immunotherapy Industry Impact
2.5.1 CAR T-Cell Immunotherapy Business Impact Assessment - Covid-19
2.5.2 Market Trends and CAR T-Cell Immunotherapy Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19

3 Competition by Vendors
3.1 Global CAR T-Cell Immunotherapy Revenue and Market Share by Vendors (2016-2021)
3.2 Global CAR T-Cell Immunotherapy Industry Concentration Ratio (CR5 and HHI)
3.3 Top 5 CAR T-Cell Immunotherapy Vendors Market Share
3.4 Top 10 CAR T-Cell Immunotherapy Vendors Market Share
3.5 Date of Key Vendors Enter into CAR T-Cell Immunotherapy Market
3.6 Key Vendors CAR T-Cell Immunotherapy Product Offered
3.7 Mergers & Acquisitions Planning

4 Analysis of CAR T-Cell Immunotherapy Industry Key Vendors
4.1 AbbVie
4.1.1 Company Details
4.1.2 Product Introduction, Application and Specification
4.1.3 AbbVie CAR T-Cell Immunotherapy Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 AbbVie News
4.2 Cellectis
4.2.1 Company Details
4.2.2 Product Introduction, Application and Specification
4.2.3 Cellectis CAR T-Cell Immunotherapy Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 Cellectis News
4.3 Oxford BioMedica
4.3.1 Company Details
4.3.2 Product Introduction, Application and Specification
4.3.3 Oxford BioMedica CAR T-Cell Immunotherapy Gross Margin, and Revenue (2016-2021)
4.3.4 Main Business Overview
4.3.5 Oxford BioMedica News
4.4 Celgene
4.4.1 Company Details
4.4.2 Product Introduction, Application and Specification
4.4.3 Celgene CAR T-Cell Immunotherapy Gross Margin, and Revenue (2016-2021)
4.4.4 Main Business Overview
4.4.5 Celgene News
4.5 Pfizer
4.5.1 Company Details
4.5.2 Product Introduction, Application and Specification
4.5.3 Pfizer CAR T-Cell Immunotherapy Gross Margin, and Revenue (2016-2021)
4.5.4 Main Business Overview
4.5.5 Pfizer News
4.6 Kite Pharma
4.6.1 Company Details
4.6.2 Product Introduction, Application and Specification
4.6.3 Kite Pharma CAR T-Cell Immunotherapy Gross Margin, and Revenue (2016-2021)
4.6.4 Main Business Overview
4.6.5 Kite Pharma News
4.7 Mustang Bio
4.7.1 Company Details
4.7.2 Product Introduction, Application and Specification
4.7.3 Mustang Bio CAR T-Cell Immunotherapy Gross Margin, and Revenue (2016-2021)
4.7.4 Main Business Overview
4.7.5 Mustang Bio News
4.8 Gilead
4.8.1 Company Details
4.8.2 Product Introduction, Application and Specification
4.8.3 Gilead CAR T-Cell Immunotherapy Gross Margin, and Revenue (2016-2021)
4.8.4 Main Business Overview
4.8.5 Gilead News
4.9 Novartis
4.9.1 Company Details
4.9.2 Product Introduction, Application and Specification
4.9.3 Novartis CAR T-Cell Immunotherapy Gross Margin, and Revenue (2016-2021)
4.9.4 Main Business Overview
4.9.5 Novartis News
4.10 Bellicum
4.10.1 Company Details
4.10.2 Product Introduction, Application and Specification
4.10.3 Bellicum CAR T-Cell Immunotherapy Gross Margin, and Revenue (2016-2021)
4.10.4 Main Business Overview
4.10.5 Bellicum News
4.11 Ziopharm Oncology
4.11.1 Company Details
4.11.2 Product Introduction, Application and Specification
4.11.3 Ziopharm Oncology CAR T-Cell Immunotherapy Gross Margin, and Revenue (2016-2021)
4.11.4 Main Business Overview
4.11.5 Ziopharm Oncology News
4.12 CARsgen Therapeutics
4.12.1 Company Details
4.12.2 Product Introduction, Application and Specification
4.12.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Gross Margin, and Revenue (2016-2021)
4.12.4 Main Business Overview
4.12.5 CARsgen Therapeutics News
4.13 Aurora Biopharma
4.13.1 Company Details
4.13.2 Product Introduction, Application and Specification
4.13.3 Aurora Biopharma CAR T-Cell Immunotherapy Gross Margin, and Revenue (2016-2021)
4.13.4 Main Business Overview
4.13.5 Aurora Biopharma News
4.14 Adaptimmune
4.14.1 Company Details
4.14.2 Product Introduction, Application and Specification
4.14.3 Adaptimmune CAR T-Cell Immunotherapy Gross Margin, and Revenue (2016-2021)
4.14.4 Main Business Overview
4.14.5 Adaptimmune News
4.15 Xyphos
4.15.1 Company Details
4.15.2 Product Introduction, Application and Specification
4.15.3 Xyphos CAR T-Cell Immunotherapy Gross Margin, and Revenue (2016-2021)
4.15.4 Main Business Overview
4.15.5 Xyphos News
4.16 Creative Biolabs
4.16.1 Company Details
4.16.2 Product Introduction, Application and Specification
4.16.3 Creative Biolabs CAR T-Cell Immunotherapy Gross Margin, and Revenue (2016-2021)
4.16.4 Main Business Overview
4.16.5 Creative Biolabs News
4.17 Minerva Biotechnologies
4.17.1 Company Details
4.17.2 Product Introduction, Application and Specification
4.17.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Gross Margin, and Revenue (2016-2021)
4.17.4 Main Business Overview
4.17.5 Minerva Biotechnologies News

5 Global CAR T-Cell Immunotherapy Market Size Categorized by Regions
5.1 Global CAR T-Cell Immunotherapy Revenue and Market Share by Regions
5.2 North America CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
5.3 Europe CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
5.4 Asia-pacific CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
5.5 South America CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
5.6 Middle East & Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)

6 North America CAR T-Cell Immunotherapy Market Size Categorized by Countries
6.1 North America CAR T-Cell Immunotherapy Revenue and Market Share by Countries
6.1.1 North America CAR T-Cell Immunotherapy Market Size by Countries (2016-2021)
6.1.2 United States CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
6.1.3 Canada CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
6.1.4 Mexico CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
6.2 North America CAR T-Cell Immunotherapy Revenue (Value) by Vendors
6.3 North America CAR T-Cell Immunotherapy Revenue and Market Share by Type (2016-2021)
6.4 North America CAR T-Cell Immunotherapy Revenue and Market Share by Application (2016-2021)

7 Europe CAR T-Cell Immunotherapy Market Size Categorized by Countries
7.1 Europe CAR T-Cell Immunotherapy Revenue and Market Share by Countries
7.1.1 Europe CAR T-Cell Immunotherapy Market Size by Countries (2016-2021)
7.1.2 Germany CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
7.1.3 UK CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
7.1.4 France CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
7.1.5 Russia CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
7.1.6 Italy CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
7.1.7 Spain CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
7.2 Europe CAR T-Cell Immunotherapy Revenue (Value) by Vendors
7.3 Europe CAR T-Cell Immunotherapy Revenue and Market Share by Type (2016-2021)
7.4 Europe CAR T-Cell Immunotherapy Revenue and Market Share by Application (2016-2021)

8 Asia-pacific CAR T-Cell Immunotherapy Market Size Categorized by Countries
8.1 Asia-pacific CAR T-Cell Immunotherapy Revenue and Market Share by Countries
8.1.1 Asia-pacific CAR T-Cell Immunotherapy Market Size by Countries (2016-2021)
8.1.2 China CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
8.1.3 South Korea CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
8.1.4 Japan CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
8.1.5 Australia CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
8.1.6 India CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
8.1.7 Southeast Asia CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
8.2 Asia-pacific CAR T-Cell Immunotherapy Revenue (Value) by Vendors
8.3 Asia-pacific CAR T-Cell Immunotherapy Revenue and Market Share by Type (2016-2021)
8.4 Asia-pacific CAR T-Cell Immunotherapy Revenue and Market Share by Application (2016-2021)

9 South America CAR T-Cell Immunotherapy Market Size Categorized by Countries
9.1 South America CAR T-Cell Immunotherapy Revenue and Market Share by Countries
9.1.1 South America CAR T-Cell Immunotherapy Market Size by Countries (2016-2021)
9.1.2 Brazil CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
9.1.3 Chile CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
9.2 South America CAR T-Cell Immunotherapy Revenue and Market Share by Type (2016-2021)
9.3 South America CAR T-Cell Immunotherapy Revenue and Market Share by Application (2016-2021)

10 Middle East and Africa CAR T-Cell Immunotherapy Market Size Categorized by Countries
10.1 Middle East and Africa CAR T-Cell Immunotherapy Revenue and Market Share by Countries
10.1.1 Middle East and Africa CAR T-Cell Immunotherapy Market Size by Countries (2016-2021)
10.1.2 GCC Countries CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
10.1.3 Turkey CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
10.1.4 Egypt CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
10.1.5 South Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
10.2 Middle East and Africa CAR T-Cell Immunotherapy Revenue and Market Share by Type
10.3 Middle East and Africa CAR T-Cell Immunotherapy Revenue Market Share by Application (2016-2021)

11 Global CAR T-Cell Immunotherapy Market Segment by Type
11.1 Global CAR T-Cell Immunotherapy Revenue and Market Share by Type (2016-2021)
11.2 Monotherapy Revenue Growth Rate and Price
11.3 Combination Therapy Revenue Growth Rate and Price

12 Global CAR T-Cell Immunotherapy Market Segment by Application
12.1 Global CAR T-Cell Immunotherapy Revenue Market Share by Application (2016-2021)
12.2 Hematologic Malignancies Revenue Growth Rate (2016-2021)
12.3 Solid Malignancies Revenue Growth Rate (2016-2021)

13 Global CAR T-Cell Immunotherapy Market Forecast
13.1 Global CAR T-Cell Immunotherapy Revenue and Growth Rate (2021-2026)
13.2 CAR T-Cell Immunotherapy Market Forecast by Regions (2021-2026)
13.2.1 North America CAR T-Cell Immunotherapy Market Forecast (2021-2026)
13.2.2 Europe CAR T-Cell Immunotherapy Market Forecast (2021-2026)
13.2.3 Asia-Pacific CAR T-Cell Immunotherapy Market Forecast (2021-2026)
13.2.4 South America CAR T-Cell Immunotherapy Market Forecast (2021-2026)
13.2.5 Middle East & Africa CAR T-Cell Immunotherapy Market Forecast (2021-2026)
13.3 CAR T-Cell Immunotherapy Market Forecast by Type (2021-2026)
13.3.1 Global CAR T-Cell Immunotherapy Revenue Forecast by Type (2021-2026)
13.3.2 Global CAR T-Cell Immunotherapy Market Share Forecast by Type (2021-2026)
13.4 CAR T-Cell Immunotherapy Market Forecast by Application (2021-2026)
13.4.1 Global CAR T-Cell Immunotherapy Revenue Forecast by Application (2021-2026)

14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis

15 Downstream Market Analysis
15.1 Macro Analysis of Down Markets
15.2 Key Players in Down Markets

16 Research Findings and Conclusion


List of Tables and Figures

Figure Product Picture CAR T-Cell Immunotherapy
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global CAR T-Cell Immunotherapy Market Size (Million US$) by Type
Figure Global Market Share of CAR T-Cell Immunotherapy by Type in 2020
Figure Monotherapy Picture
Figure Combination Therapy Picture
Table Global CAR T-Cell Immunotherapy Market Size (Million US$) by Application
Figure Global CAR T-Cell Immunotherapy Market Share by Application in 2020
Figure Hematologic Malignancies Picture
Figure Solid Malignancies Picture
Table Global CAR T-Cell Immunotherapy Comparison by Regions (M USD) 2016-2026
Figure Global CAR T-Cell Immunotherapy Market Size (Million US$) (2016-2026)
Figure North America CAR T-Cell Immunotherapy Revenue (Million US$) Growth Rate (2016-2026)
Figure Europe CAR T-Cell Immunotherapy Revenue (Million US$) Growth Rate (2016-2026)
Figure Asia-pacific CAR T-Cell Immunotherapy Revenue (Million US$) Growth Rate (2016-2026)
Figure South America CAR T-Cell Immunotherapy Revenue (Million US$) Growth Rate (2016-2026)
Figure Middle East & Africa CAR T-Cell Immunotherapy Revenue (Million US$) Growth Rate (2016-2026)
Table Business Impact Assessment - Covid-19
Table Market Trends and CAR T-Cell Immunotherapy Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global CAR T-Cell Immunotherapy Revenue by Vendors (2016-2021)
Figure Global CAR T-Cell Immunotherapy Revenue Market Share by Vendors in 2020
Table Global CAR T-Cell Immunotherapy Vendors Market Concentration Ratio (CR5 and HHI)
Figure Top 5 CAR T-Cell Immunotherapy Vendors (Revenue) Market Share in 2020
Figure Top 10 CAR T-Cell Immunotherapy Vendors (Revenue) Market Share in 2020
Table Date of Key Vendors Enter into CAR T-Cell Immunotherapy Market
Table Key Vendors CAR T-Cell Immunotherapy Product Type
Table AbbVie Company Profile
Table CAR T-Cell Immunotherapy Product Introduction, Application and Specification of AbbVie
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin of AbbVie 2016-2021
Table AbbVie Main Business
Table AbbVie Recent Development
Table Cellectis Company Profile
Table CAR T-Cell Immunotherapy Product Introduction, Application and Specification of Cellectis
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin of Cellectis 2016-2021
Table Cellectis Main Business
Table Cellectis Recent Development
Table Cellectis Company Profile
Table CAR T-Cell Immunotherapy Product Introduction, Application and Specification of Cellectis
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin of Cellectis 2016-2021
Table Cellectis Main Business
Table Cellectis Recent Development
Table Oxford BioMedica Company Profile
Table CAR T-Cell Immunotherapy Product Introduction, Application and Specification of Oxford BioMedica
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin of Oxford BioMedica 2016-2021
Table Oxford BioMedica Main Business
Table Oxford BioMedica Recent Development
Table Celgene Company Profile
Table CAR T-Cell Immunotherapy Product Introduction, Application and Specification of Celgene
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin of Celgene 2016-2021
Table Celgene Main Business
Table Celgene Recent Development
Table Pfizer Company Profile
Table CAR T-Cell Immunotherapy Product Introduction, Application and Specification of Pfizer
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin of Pfizer 2016-2021
Table Pfizer Main Business
Table Pfizer Recent Development
Table Kite Pharma Company Profile
Table CAR T-Cell Immunotherapy Product Introduction, Application and Specification of Kite Pharma
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin of Kite Pharma 2016-2021
Table Kite Pharma Main Business
Table Kite Pharma Recent Development
Table Mustang Bio Company Profile
Table CAR T-Cell Immunotherapy Product Introduction, Application and Specification of Mustang Bio
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin of Mustang Bio 2016-2021
Table Mustang Bio Main Business
Table Mustang Bio Recent Development
Table Gilead Company Profile
Table CAR T-Cell Immunotherapy Product Introduction, Application and Specification of Gilead
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin of Gilead 2016-2021
Table Gilead Main Business
Table Gilead Recent Development
Table Novartis Company Profile
Table CAR T-Cell Immunotherapy Product Introduction, Application and Specification of Novartis
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin of Novartis 2016-2021
Table Novartis Main Business
Table Novartis Recent Development
Table Bellicum Company Profile
Table CAR T-Cell Immunotherapy Product Introduction, Application and Specification of Bellicum
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin of Bellicum 2016-2021
Table Bellicum Main Business
Table Bellicum Recent Development
Table Ziopharm Oncology Company Profile
Table CAR T-Cell Immunotherapy Product Introduction, Application and Specification of Ziopharm Oncology
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin of Ziopharm Oncology 2016-2021
Table Ziopharm Oncology Main Business
Table Ziopharm Oncology Recent Development
Table CARsgen Therapeutics Company Profile
Table CAR T-Cell Immunotherapy Product Introduction, Application and Specification of CARsgen Therapeutics
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin of CARsgen Therapeutics 2016-2021
Table CARsgen Therapeutics Main Business
Table CARsgen Therapeutics Recent Development
Table Aurora Biopharma Company Profile
Table CAR T-Cell Immunotherapy Product Introduction, Application and Specification of Aurora Biopharma
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin of Aurora Biopharma 2016-2021
Table Aurora Biopharma Main Business
Table Aurora Biopharma Recent Development
Table Adaptimmune Company Profile
Table CAR T-Cell Immunotherapy Product Introduction, Application and Specification of Adaptimmune
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin of Adaptimmune 2016-2021
Table Adaptimmune Main Business
Table Adaptimmune Recent Development
Table Xyphos Company Profile
Table CAR T-Cell Immunotherapy Product Introduction, Application and Specification of Xyphos
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin of Xyphos 2016-2021
Table Xyphos Main Business
Table Xyphos Recent Development
Table Creative Biolabs Company Profile
Table CAR T-Cell Immunotherapy Product Introduction, Application and Specification of Creative Biolabs
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin of Creative Biolabs 2016-2021
Table Creative Biolabs Main Business
Table Creative Biolabs Recent Development
Table Minerva Biotechnologies Company Profile
Table CAR T-Cell Immunotherapy Product Introduction, Application and Specification of Minerva Biotechnologies
Table CAR T-Cell Immunotherapy Revenue (M USD) and Gross Margin of Minerva Biotechnologies 2016-2021
Table Minerva Biotechnologies Main Business
Table Minerva Biotechnologies Recent Development
Table Mergers & Acquisitions Planning
Figure Global CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Figure Global CAR T-Cell Immunotherapy Revenue by Regions (2016-2021)
Figure Global CAR T-Cell Immunotherapy Revenue Market Share by Regions in 2020
Figure North America CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Figure Europe CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Figure Asia-pacific CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Figure South America CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Figure Middle East & Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Figure North America CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Table North America CAR T-Cell Immunotherapy Market Size by Countries (2016-2021)
Table North America CAR T-Cell Immunotherapy Market Share by Countries (2016-2021)
Figure North America CAR T-Cell Immunotherapy Market Share by Countries in 2020
Figure United States CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Figure Canada CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Figure Mexico CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Table North America CAR T-Cell Immunotherapy Revenue by Vendors (2020)
Figure North America CAR T-Cell Immunotherapy Revenue Market Share by Vendors in 2020
Table North America CAR T-Cell Immunotherapy Revenue by Type (2016-2021)
Table North America CAR T-Cell Immunotherapy Share by Type (2016-2021)
Table North America CAR T-Cell Immunotherapy Revenue by Application (2016-2021)
Table North America CAR T-Cell Immunotherapy Revenue Share by Application (2016-2021)
Figure Europe CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Table Europe CAR T-Cell Immunotherapy Market Size by Countries (2016-2021)
Table Europe CAR T-Cell Immunotherapy Revenue Market Share by Countries (2016-2021)
Figure Europe CAR T-Cell Immunotherapy Revenue Market Share by Countries in 2020
Figure Germany CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Figure UK CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Figure France CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Figure Russia CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Figure Italy CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Figure Spain CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Table Europe CAR T-Cell Immunotherapy Revenue by Vendors (2020)
Figure Europe CAR T-Cell Immunotherapy Revenue Market Share by Vendors in 2020
Table Europe CAR T-Cell Immunotherapy Revenue by Type (2016-2021)
Table Europe CAR T-Cell Immunotherapy Revenue Share by Type (2016-2021)
Table Europe CAR T-Cell Immunotherapy Revenue by Application (2016-2021)
Table Europe CAR T-Cell Immunotherapy Revenue Share by Application (2016-2021)
Figure Asia-pacific CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Table Asia-pacific CAR T-Cell Immunotherapy Market Size by Countries (2016-2021)
Table Asia-pacific CAR T-Cell Immunotherapy Revenue Market Share by Countries (2016-2021)
Figure Asia-pacific CAR T-Cell Immunotherapy Revenue Market Share by Countries in 2020
Figure China CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Figure South Korea CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Figure Japan CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Figure Australia CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Figure India CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Figure Southeast Asia CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Table Asia-pacific CAR T-Cell Immunotherapy Revenue by Vendors (2020)
Figure Asia-pacific CAR T-Cell Immunotherapy Revenue Market Share by Vendors in 2020
Table Asia-pacific CAR T-Cell Immunotherapy Revenue by Type (2016-2021)
Table Asia-pacific CAR T-Cell Immunotherapy Revenue Share by Type (2016-2021)
Table Asia-pacific CAR T-Cell Immunotherapy Revenue by Application (2016-2021)
Table Asia-pacific CAR T-Cell Immunotherapy Revenue Share by Application (2016-2021)
Figure South America CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Table South America CAR T-Cell Immunotherapy Revenue Market Size by Countries (2016-2021)
Table South America CAR T-Cell Immunotherapy Revenue Market Share by Countries (2016-2021)
Figure South America CAR T-Cell Immunotherapy Revenue Market Share by Countries in 2019
Figure Brazil CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Figure Chile CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Table South America CAR T-Cell Immunotherapy Revenue s by Type (2016-2021)
Table South America CAR T-Cell Immunotherapy Revenue Share by Type (2016-2021)
Table South America CAR T-Cell Immunotherapy Revenue by Application (2016-2021)
Table South America CAR T-Cell Immunotherapy Revenue Share by Application (2016-2021)
Figure Middle East and Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Table Middle East and Africa CAR T-Cell Immunotherapy Market Size by Countries (2016-2021)
Table Middle East and Africa CAR T-Cell Immunotherapy Sales Market Share by Countries (2016-2021)
Figure Middle East and Africa CAR T-Cell Immunotherapy Sales Market Share by Countries in 2019
Figure GCC Countries CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Figure Turkey CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Figure Egypt CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Figure South Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2021)
Table Middle East and Africa CAR T-Cell Immunotherapy Revenue by Type (2016-2021)
Table Middle East and Africa CAR T-Cell Immunotherapy Revenue Share by Type (2016-2021)
Table Middle East and Africa CAR T-Cell Immunotherapy Revenue by Application (2016-2021)
Table Middle East and Africa CAR T-Cell Immunotherapy Revenue Share by Application (2016-2021)
Table Global CAR T-Cell Immunotherapy Revenue by Type (2016-2021)
Table Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2016-2021)
Figure Global CAR T-Cell Immunotherapy Revenue Market Share by Type in 2019
Figure Global Monotherapy Revenue and Growth Rate (2016-2021)
Figure Global Combination Therapy Revenue and Growth Rate (2016-2021)
Table Global CAR T-Cell Immunotherapy Revenue by Application (2016-2021)
Table Global CAR T-Cell Immunotherapy Revenue Market Share by Application (2016-2021)
Figure Global CAR T-Cell Immunotherapy Revenue Market Share by Application in 2020
Figure Global Hematologic Malignancies Revenue Growth Rate (2016-2021)
Figure Global Solid Malignancies Revenue Growth Rate (2016-2021)
Figure Global CAR T-Cell Immunotherapy Revenue and Growth Rate (2021-2026)
Table Global CAR T-Cell Immunotherapy Revenue Forecast by Regions (2021-2026)
Table Global CAR T-Cell Immunotherapy Market Share Forecast by Regions (2021-2026)
Figure North America Revenue CAR T-Cell Immunotherapy Market Forecast (2021-2026)
Figure Europe Revenue CAR T-Cell Immunotherapy Market Forecast (2021-2026)
Figure Asia-Pacific Revenue CAR T-Cell Immunotherapy Market Forecast (2021-2026)
Figure South America Revenue CAR T-Cell Immunotherapy Market Forecast (2021-2026)
Figure Middle East & Africa Revenue CAR T-Cell Immunotherapy Market Forecast (2021-2026)
Table Global CAR T-Cell Immunotherapy Revenue Forecast by Type (2021-2026)
Table Global CAR T-Cell Immunotherapy Market Share Forecast by Type (2021-2026)
Table Global CAR T-Cell Immunotherapy Revenue Forecast by Application (2021-2026)
Table Global CAR T-Cell Immunotherapy Market Share Forecast by Application (2021-2026)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Author List

AbbVie
Cellectis
Oxford BioMedica
Celgene
Pfizer
Kite Pharma
Mustang Bio
Gilead
Novartis
Bellicum
Ziopharm Oncology
CARsgen Therapeutics
Aurora Biopharma
Adaptimmune
Xyphos
Creative Biolabs
Minerva Biotechnologies